Exact Mass: 262.1061
Exact Mass Matches: 262.1061
Found 121 metabolites which its exact mass value is equals to given mass value 262.1061
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
1,6-Dimethoxypyrene
This compound belongs to the family of Pyrenes. These are compounds containing a pyrene moiety, which consists four fused benzene rings, resulting in a flat aromatic system.
Hydroxyprolyl-Methionine
Hydroxyprolyl-Methionine is a dipeptide composed of hydroxyproline and methionine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
Methionylhydroxyproline
Methionylhydroxyproline is a dipeptide composed of methionine and hydroxyproline. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
3-Deazaneplanocin
9-Hydroxyellipticine
D000970 - Antineoplastic Agents > D000972 - Antineoplastic Agents, Phytogenic > D004611 - Ellipticines D009676 - Noxae > D000963 - Antimetabolites
(1E,3E,9Z)-1-Chlorohexadeca-5,7-diyne-1,3,9-trien-15-ol|(1E,3E,9Z)-1-chlorohexadeca-5,7-diyne-1,3,9-triene-15-ol
(1E,3E,9Z)-1-Chlorohexadeca-5,7-diyne-1,3,9-trien-14-ol|(1Z,3E,9Z)-1-chlorohexadeca-5,7-diyne-1,3,9-triene-14-ol
(E)-[5-(5-Methylhtien-2-yl)-2-penten-4-ynyl]-3-methylbutanoate
3-methyl-2-butenoic acid 1-O-beta-D-glucopyranoside|thotneoside C
Deoxy,3-acetoxy,4,5-dihydro-9-(2-Thieenyl)-4,6-nonadien-8-yl-1-ol
3-deazaneplanocin
6-deuterio-1-[(2R,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(trideuteriomethyl)pyrimidine-2,4-dione
4-CHLOROACETYL-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER
1,2-O-ISOPROPYLIDENE-ALPHA-D-GLUCOFURANOSE 3-ACETATE
5-NITRO-1-PIPERIDIN-4-YL-1,3-DIHYDRO-BENZOIMIDAZOL-2-ONE
VUF 10166
VUF10166 is a potent and high-affinity 5-HT3 receptor antagonist, with Ki values of 0.04 nM (5-HT3A) and 22 nM (5-HT3AB). VUF10166 inhibits 5-HT-induced responses at 5-HT3A and 5-HT3AB receptors at nanomolar concentrations. At 5-HT3 receptor, VUF10166 at higher concentrations also acts as a partial agonist, with an EC50 of 5.2 μM[1].
[1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolo[2,3-c]pyridin-3-yl]boronic acid
cyclohexylmethyl-pyridin-3-yl-amine dihydrochloride
dimethyl 1-(2-chloroethyl)cyclohexane-1,4-dicarboxylate
5-NITROSPIRO[BENZIMIDAZOLE-2,1-CYCLOHEXAN]-4-AMINE 1-OXIDE
(2-ISOBUTOXY-5-(TRIFLUOROMETHYL)PHENYL)BORONIC ACID
4-[(4-chlorophenyl)methyl]-3-[(2R)-pyrrolidin-2-yl]-1,2,4-triazole
ethyl 3-[1-(4-fluorophenyl)ethyl]imidazole-4-carboxylate
3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-BORONIC ACID, PINACOL ESTER
1-(pyrrolidin-1-ylsulfonyl)piperidine-3-carboxylic acid
(E)-3-(2-methyl-1H-indol-3-yl)-1-pyridin-4-ylprop-2-en-1-one
(2S)-1-Amino-3-[(5-nitroquinolin-8-YL)amino]propan-2-OL
(2S,3R)-3-hydroxy-2-(7-sulfanylheptanoylamino)butanoate
2-(4-Methylphenyl)-1,9b-dihydropyrazolo[1,5-b]isoindol-5-one
5-[(2-amino-1H-benzimidazol-6-yl)amino]-5-oxopentanoic acid
N-(3,5,5-trimethyl-2-cyclohexenyliden)-2-thiophenecarbohydrazide
5-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]-3-oxopentanoic acid
5-[(2-amino-1H-3,1-benzimidazol-3-ium-6-yl)amino]-5-oxopentanoate
(4R)-4-[(2S,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxopentanoic acid
1H-Indole-2,3-dione, 1-(trimethylsilyl)-, 3-(O-ethyloxime)
5,11-Dimethyl-6H-pyrido[4,3-b]carbazol-9-ol
D000970 - Antineoplastic Agents > D000972 - Antineoplastic Agents, Phytogenic > D004611 - Ellipticines D009676 - Noxae > D000963 - Antimetabolites
cresyl violet
A cationic heterotetracyclic fluorescent dye derived from benzo[a]phenoxazine.